News & Events
Home - News & Events - Grateful for Colleagues and Building Dreams for the Future

Grateful for Colleagues and Building Dreams for the Future

Jan. 13, 2025

2025 New Year Address: General Manager of Lianhe Aigen, Jerry Zhang

 

Dear Colleagues and Friends,

 

Greetings!

 

As the Spring Festival is approaching, I would like to extend my most sincere greetings and heartfelt thanks to all of you. I wish everyone a prosperous and fulfilling new year, with good fortune, success in all your endeavors, and happiness and health in the year ahead!

 

 Grateful for Colleagues and Building Dreams for the Future

 

2024 is a year full of challenges and opportunities. Faced with the complex changes in both domestic and international markets, as well as the rapid technological and market iteration in the pharmaceutical industry, under the leadership of the board of directors of Lianhe Aigen, our company has successfully delivered commercial products and completed several challenging validation projects through the collective efforts, close collaboration, and relentless hard work of our team. Thank you all for your hard work and perseverance over the past year. It is your wisdom and sweat that have enabled Lianhe Aigen to maintain a stable and successful presence in the fierce competition of the CDMO market.

 

In the new year, we must continue to maintain our determination. George Merck, a pioneer in the pharmaceutical industry, once said: "We should always remember that medicines are made for humans, not for the pursuit of profit." As long as we stick to this belief, profits will follow. We are committed to creating a better and healthier life for mankind in the field of medical services, and we have fulfilled the mission of the company. Whenever we think of the products we produce, which can help innovative drug companies treat various diseases, and even improve the quality of life and prolong the lives of patients with lung cancer and chronic myeloid leukemia, our sense of mission, happiness, and value doubles, which also drives us to create more value for society. What Kazuo Inamori said, "A family that accumulates good will surely have more blessings," also applies to the development of enterprises.

 

As the times change and scientific knowledge is changing with each passing day, we need to improve our capabilities to meet the requirements of future pharmaceutical development. First of all, we need to have the ability to strategically predict and plan the market. Doing the right thing is the first priority, because there is no way to do the wrong thing right. Secondly, we need to enhance our operational capabilities covering all aspects of R&D, production and quality control. Traditionally speaking, production capacity and quality control capabilities are also crucial, as they can ensure that drugs are safe, effective and of controllable quality. At the same time, as a production platform mainly based on chemistry, EHS management capabilities are very important to us and are a necessary condition for our success. And project management capabilities largely determine customer satisfaction.

 

With the increasing diversification of the mechanisms of action of drugs, for example, our traditional chemical small molecules were targets for antagonizing related diseases, and now the siRNA technology can directly silence pathogenic genes. For the future technological direction, we must have the ability to plan and implement the new technology in early phase.

 

Efforts are the key to transforming willpower and ability into actual results. In the pharmaceutical process, every technological advancement improves the effectiveness of the drug; conversely, slight errors in every link may affect the quality, safety and efficacy of the drug. Therefore, CDMO pharmaceutical companies need to make great efforts to strive for excellence in every link, from raw material inspection, synthesis, purification to packaging. This effort is not only reflected in the quality control of the product, but also in the continuous innovation of technology and the in-depth expansion of the market, and also in our spirit of being the owner of the company, constantly reducing costs and increasing efficiency.

 

We need to guard against arrogance and impatience, be prepared for danger in times of peace, and through continuous struggle, transform our will and ability into actual products and services to improve customer satisfaction. Finally, I wish Lianhe Aigen will have a broader road and bring healthier lives to patients around the world.


What Can We Help You?

We provide customers with one-stop CRDMO services covering the entire lifecycle of drugs.

Introduction

We use cookies on our website to better understand how you use our website. For more information about how we use cookies, please visit our Terms of Use and Legal Notices and Privacy Statement and Cookies Policy. By continuing to use this website without changing your settings, you will be deemed to have consented to our use of cookies.